Access the updated page using the API Locator.   Our Custom Search for Pharma News…

FDA Approval Activities for this Drug… Triamterene and Hydrochlorothiazide Capsules USP, 37.5 mg/25 mg. Barr, ANDA 74-970 1/6/98 3/15/99 Triamterene and Hydrochlorothiazide Capsules USP, 37.5 mg/25 mg, Duramed ANDA 75-052 | Dyazide (hydrochlorothiazide/triamterene) Capsules, GlaxoSmithKline, Labeling Revision | Triamterene and Hydrochlorothiazide Capsules, Mylan Pharma, Control Suppl. | Dyazide (hydrochlorothiazide and triamterene) Capsules, GlaxoSmithKline, Labeling Revision | Dyazide (hydrochlorothiazide and triamterene) Capsules, GlaxoSmithKlein, Labeling Revision | Maxzide (hydrochlorothiazide and triamterene) Tablets, Mylan Pharmaceuticals Inc., Labeling Revision View updates.                                                                       A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News | VOIP © 2012 Betterchem.com